InsiderClue
← All stocks

Taysha Gene Therapies, Inc.

TSHA Net selling
CIK 0001806310 #2058 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$6.66M
$1.25M on a plan · $3.53M straight out of an exercise
Sold at will
$1.88M
7 of 12 sales
Net
−$6.66M
−$1.88M against sales at will

By person

8 insiders · 12 transactions
28.0×

Sean Nolan holds 28.0 times base salary in stock. $18.15M of shares against $645.84K in salary for 2025.

Salary from the company's own proxy. The shares are what Sean Nolan last reported holding, valued at $6.24, the price Common Stock was last bought or sold at on the open market here, on 10 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Nagendran Sukumar
President and Head of R&D
—
$5.33M (7) scheduled
−$5.33M
936,410
0.2874%
$5.84M
+4.3%
Nolan Sean P.
Chief Executive Officer
—
$840.20K (2)
−$840.20K
2,908,257
0.8926%
$18.15M
+145.2%
Alam Kamran
CHIEF FINANCIAL OFFICER
—
$492.52K (3)
−$492.52K
1,442,131
0.4426%
$9.00M
+71.5%
Manning Paul B
10% owner
—
—
—
2,841,704
0.8721%
$17.73M
+35.9%
Stalfort John A III
Director
—
—
—
1,176,559
0.3611%
$7.34M
+7.1%
Donenberg Phillip B.
Director
—
—
—
241,289
0.0741%
$1.51M
+47.7%
Long Alison S
Director
—
—
—
127,178
0.0390%
$793.59K
+158.4%
Sepp-Lorenzino Laura
Director
—
—
—
127,178
0.0390%
$793.59K
+158.4%

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Nagendran Sukumar
10 Jul 2026
President and Head of R&D
Sold on a plan
200,000
$6.24
$1.25M
Nagendran Sukumar
10 Apr 2026
President and Head of R&D
Sold after exercise
200,000
$4.46
$892.00K
Alam Kamran
4 Feb 2026
CHIEF FINANCIAL OFFICER
Sell
1,655
$4.52
$7.48K
Alam Kamran
26 Jan 2026
CHIEF FINANCIAL OFFICER
Sell
23,849
$4.61
$109.94K
Nolan Sean P.
26 Jan 2026
Chief Executive Officer
Sell
41,312
$4.61
$190.45K
Nagendran Sukumar
26 Jan 2026
President and Head of R&D
Sell
26,918
$4.61
$124.09K
Alam Kamran
23 Jan 2026
CHIEF FINANCIAL OFFICER
Sell
78,968
$4.75
$375.10K
Nolan Sean P.
23 Jan 2026
Chief Executive Officer
Sell
136,789
$4.75
$649.75K
Nagendran Sukumar
23 Jan 2026
President and Head of R&D
Sell
89,132
$4.75
$423.38K
Nagendran Sukumar
12 Jan 2026
President and Head of R&D
Sold after exercise
200,000
$4.71
$942.00K
Nagendran Sukumar
1 Dec 2025
President and Head of R&D
Sold after exercise
260,047
$4.51
$1.17M
Nagendran Sukumar
28 Nov 2025
President and Head of R&D
Sold after exercise
110,125
$4.75
$523.09K

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 4
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,468,533
History held since 25 Sep 2020